Cargando…

Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin

We encountered a case in which the general condition of a patient receiving cabazitaxel worsened with concomitant use of clarithromycin. Cabazitaxel is metabolized mainly by CYP3A4, and the frequency of adverse events is known to increase with increasing exposure. Although these drugs are not often...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsumi, Shigeaki, Araki, Takuya, Yashima, Hideaki, Miyazawa, Yoshiyuki, Suzuki, Kazuhiro, Yamamoto, Koujirou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359678/ https://www.ncbi.nlm.nih.gov/pubmed/37485011 http://dx.doi.org/10.1159/000530547

Ejemplares similares

Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high-dose methotrexate based on individual pharmacokinetics: A retrospective study
por: Nagamine, Ayumu, et al.
Publicado: (2022)

Increased c‑SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma
por: Takahashi, Masamitsu, et al.
Publicado: (2023)

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2013)

Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2012)

Effect of Ethanol in Paclitaxel Injections on the Ethanol Concentration in Exhaled Breath
por: Aomori, Tohru, et al.
Publicado: (2012)

Preclinical profile of cabazitaxel
por: Vrignaud, Patricia, et al.
Publicado: (2014)

Topical Drug Delivery of Concentrated Cabazitaxel in an α‐Tocopherol and DMSO Solution
por: Sun, Boyang, et al.
Publicado: (2023)

Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin
por: Takeuchi, Sayako, et al.
Publicado: (2017)

Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
por: Yamamoto, Yoshiyuki
Publicado: (2019)

Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3
por: Ito, Ayano, et al.
Publicado: (2017)

Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy
por: Nelson, J. Craig, et al.
Publicado: (2014)

Whose voice? Whose choice? Whose power?
por: Chamberlin, Judi
Publicado: (2007)

Whose Copy? Whose Rights?
por: Gass, Andy, et al.
Publicado: (2004)

The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
por: Albanji, Muradi, et al.
Publicado: (2022)

Feasibility of cabazitaxel in octogenarian prostate cancer patients
por: Tralongo, Paolo, et al.
Publicado: (2023)

Safety and efficacy of cabazitaxel in Japanese patients with castration-resistant prostate cancer
por: Yamamoto, Teppei, et al.
Publicado: (2020)

Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients
por: Obayashi, Kyoko, et al.
Publicado: (2013)

The influence of Javanese turmeric (Curcuma xanthorrhiza) on the pharmacokinetics of warfarin in rats with single and multiple-dose studies
por: Rusdiana, Taofik, et al.
Publicado: (2021)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
por: Ferron, Géraldine M., et al.
Publicado: (2013)

Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate cancer patients with PTEN alterations
por: Kamisawa, Ken, et al.
Publicado: (2022)

Colchicine-induced rhabdomyolysis following a concomitant use of clarithromycin in a haemodialysis patient with familial Mediterranean fever
por: Çelebi, Zeynep Kendi, et al.
Publicado: (2013)

Effectiveness of clarithromycin in patients with yellow nail syndrome
por: Matsubayashi, Sachi, et al.
Publicado: (2018)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Concomitant Upper Extremity Fracture Worsens Outcomes in Elderly Patients With Hip Fracture
por: Thayer, Mary Kate, et al.
Publicado: (2018)

Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report
por: Hashimoto, Mamoru, et al.
Publicado: (2019)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
por: Kommineni, Nagavendra, et al.
Publicado: (2019)

Cabazitaxel Induced Thrombotic Microangiopathy in a Patient with Prostate Cancer
por: Nlandu, Yannick, et al.
Publicado: (2019)

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
por: Pobel, Cedric, et al.
Publicado: (2021)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

Development of a Plasmonic Sensor for a Chemotherapeutic Agent Cabazitaxel
por: Aşır, Süleyman, et al.
Publicado: (2022)

Whose Sperm?
por: Amann, R. P.
Publicado: (1994)

Who's whose?
por: Gooden, Philip
Publicado: (2009)

Whose Dog Is It?
Publicado: (1877)

Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease
por: Iwamoto, Junichi, et al.
Publicado: (2017)

Clarithromycin–Rifampin-Based Treatment for Nontuberculous Mycobacteria Infections in Immunocompromised Patients who Require Concomitant CYP-Metabolized Medications
por: Gonzalez-Bocco, Isabel H, et al.
Publicado: (2021)

Comment — WHO outsourcing dilemma: for whose benefit, at whose expense?
por: Sharma, Jeevan Raj, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0p9ebd2h5f8v3k4sjv8lfet0p3